Apraclonidine Hydrochloride and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Apraclonidine Hydrochloride and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: apraclonidine ophthalmic
Brand name: Iopidine
Synonyms: Apraclonidine ophthalmic, Apraclonidine
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Apraclonidine Hydrochloride-Pneumococcal 13-valent conjugate vaccine
- Apraclonidine Hydrochloride-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Apraclonidine Hydrochloride-Pneumococcal Conjugate Vaccine (13-Valent)
- Apraclonidine Hydrochloride-Pneumococcal Conjugate Vaccine (7-Valent)
- Apraclonidine Hydrochloride-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Apraclonidine Hydrochloride-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-Apraclonidine ophthalmic
- Pms-Sodium Polystyrene Sulfonate-Apremilast
- Pms-Sodium Polystyrene Sulfonate-Aprepitant
- Pms-Sodium Polystyrene Sulfonate-Aprepitant Capsules
- Pms-Sodium Polystyrene Sulfonate-Aprepitant Injection
- Pms-Sodium Polystyrene Sulfonate-Aprepitant Intravenous